<- Go Home
Global Cord Blood Corporation
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Market Cap
$980.8M
Volume
143.8K
Cash and Equivalents
$6.7B
EBITDA
$656.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.1B
Profit Margin
85.26%
52 Week High
$16.90
52 Week Low
$5.44
Dividend
N/A
Price / Book Value
0.18
Price / Earnings
1.78
Price / Tangible Book Value
0.19
Enterprise Value
-$4.7B
Enterprise Value / EBITDA
-7.15
Operating Income
$608.9M
Return on Equity
10.99%
Return on Assets
4.63
Cash and Short Term Investments
$6.7B
Debt
$147.0K
Equity
$4.9B
Revenue
$1.2B
Unlevered FCF
$378.6M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium